China's loss is India's gain as Western drug makers pivot – despite quality, oversight concerns

Pharmaceutical companies are seeking to limit their reliance on Chinese contractors who produce drugs used in clinical trials and early-stage manufacturing, industry insiders said.

Related Keywords

China ,India ,United States ,Shanghai ,Chinese ,Indian Cdmos ,Ramesh Subramanian ,Peter Deyoung ,Piramal Pharma ,Ashish Nimgaonkar ,Helen Chen ,Tommy Erdei ,Piramal Pharma Solutions ,Aragen Life Sciences ,Sai Life Sciences ,Drug Administration ,Glyscend Therapeutics ,Greater China Managing Partner ,Mordor Intelligence ,Life Sciences ,